Renal cell carcinoma (RCC) is the most common type of kidney cancer, with more than 200,000 new cases of RCC diagnosed worldwide each year, and 25-30% of kidney cancer patients diagnosed with metastatic disease. With advancements in medical science, patients with advanced RCC can now have better chances of surviving cancer as Professor Dr. Marniza Saad informs us.